These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31960098)

  • 21. Brain
    Woyk K; Sahlmann CO; Hansen N; Timäus C; Müller SJ; Khadhraoui E; Wiltfang J; Lange C; Bouter C
    J Neuroimaging; 2023 Mar; 33(2):256-268. PubMed ID: 36465027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
    Tripathi M; Tripathi M; Damle N; Kushwaha S; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
    Neuroradiol J; 2014 Feb; 27(1):13-21. PubMed ID: 24571830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
    Koeppe RA; Gilman S; Joshi A; Liu S; Little R; Junck L; Heumann M; Frey KA; Albin RL
    J Nucl Med; 2005 Jun; 46(6):936-44. PubMed ID: 15937303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of molecular imaging on the diagnostic process in a memory clinic.
    Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
    Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.
    Mosconi L; Tsui WH; Herholz K; Pupi A; Drzezga A; Lucignani G; Reiman EM; Holthoff V; Kalbe E; Sorbi S; Diehl-Schmid J; Perneczky R; Clerici F; Caselli R; Beuthien-Baumann B; Kurz A; Minoshima S; de Leon MJ
    J Nucl Med; 2008 Mar; 49(3):390-8. PubMed ID: 18287270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual Assessment of Brain Perfusion MRI Scans in Dementia: A Pilot Study.
    Fällmar D; Lilja J; Velickaite V; Danfors T; Lubberink M; Ahlgren A; van Osch MJ; Kilander L; Larsson EM
    J Neuroimaging; 2016 May; 26(3):324-30. PubMed ID: 26376736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
    Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
    J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Head-to-head comparison of cerebral blood flow single-photon emission computed tomography and
    Nadebaum DP; Krishnadas N; Poon AMT; Kalff V; Lichtenstein M; Villemagne VL; Jones G; Rowe CC
    Intern Med J; 2021 Aug; 51(8):1243-1250. PubMed ID: 32388925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Relevance of [
    Librizzi D; Cabanel N; Zavorotnyy M; Riehl E; Kircher T; Luster M; Hooshyar Yousefi B
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33652938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
    Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
    J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.
    Vijverberg EG; Wattjes MP; Dols A; Krudop WA; Möller C; Peters A; Kerssens CJ; Gossink F; Prins ND; Stek ML; Scheltens P; van Berckel BN; Barkhof F; Pijnenburg YA
    J Alzheimers Dis; 2016 Jun; 53(4):1287-97. PubMed ID: 27372646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limits for Reduction of Acquisition Time and Administered Activity in
    Schiller F; Frings L; Thurow J; Meyer PT; Mix M
    J Nucl Med; 2019 Dec; 60(12):1764-1770. PubMed ID: 31028167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparametric computer-aided differential diagnosis of Alzheimer's disease and frontotemporal dementia using structural and advanced MRI.
    Bron EE; Smits M; Papma JM; Steketee RME; Meijboom R; de Groot M; van Swieten JC; Niessen WJ; Klein S
    Eur Radiol; 2017 Aug; 27(8):3372-3382. PubMed ID: 27986990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
    Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
    Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease.
    Tiepolt S; Hesse S; Patt M; Luthardt J; Schroeter ML; Hoffmann KT; Weise D; Gertz HJ; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1700-9. PubMed ID: 27026271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose Reduction in Brain [
    Soret M; Piekarski E; Yeni N; Giron A; Maisonobe JA; Khalifé M; Zaslavsky C; Bertaux M; Habert MO; Kas A
    Mol Imaging Biol; 2020 Jun; 22(3):695-702. PubMed ID: 31286349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
    Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Use of
    Ortner MM
    Methods Mol Biol; 2018; 1750():213-219. PubMed ID: 29512075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI.
    Du AT; Jahng GH; Hayasaka S; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin KP; Miller BL; Weiner MW; Schuff N
    Neurology; 2006 Oct; 67(7):1215-20. PubMed ID: 17030755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.